Drug Shortage Report for VENLAFAXINE XR
Report ID | 171350 |
Drug Identification Number | 02516551 |
Brand name | VENLAFAXINE XR |
Common or Proper name | Venlafaxine Hydrochloride Extended-Release Capsules, Mfr. Std. |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-10-07 |
Estimated end date | 2022-11-10 |
Actual end date | 2022-10-14 |
Shortage status | Resolved |
Updated date | 2022-10-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-10-24 | French | Compare |
v4 | 2022-10-24 | English | Compare |
v3 | 2022-10-08 | English | Compare |
v2 | 2022-10-07 | French | Compare |
v1 | 2022-10-07 | English | Compare |
Showing 1 to 5 of 5